Nichakawade et al. (2024). TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers. Nature. https://doi.org/10.1038/s41586-024-07233-2
Fan, Huishou et al. (2024).Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM). Clinical cancer research . DOI: 10.1158/1078-0432.CCR-23-2767
Ren et al. (2024). Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nat Commun 15, 519 https://doi.org/10.1038/s41467-024-44786-2
Carmen Martin-Alonso et al. (2024). Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies. Science 383 doi:10.1126/science.adf2341
Shen, Lianghua et al. (2024) .Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection. Molecular therapy. https://doi.org/10.1016/j.ymthe.2023.11.017
Urbano et al. (2023). Combined analytical assays for the characterization of drugs binding to human IgE: Applicability to omalizumab-bearing biosimilar candidates assessment. Biomed Pharmacother https://doi.org/10.1016/j.biopha.2023.115848
Rezazadeh et al. (2022). Evaluation and selection of a lead diabody for interferon-γ PET imaging. Nucl Med Biol. https://doi.org/10.1016/j.nucmedbio.2022.06.001
Jo et al. (2022). Subtype-specific single β1 integrin mechanics for activation, mechanotransduction and cytoskeleton remodeling. Biorxiv 2022.06.08.495291 https://doi.org/10.1101/2022.06.08.495291
Wang et al. (2021). First Immunoassay for Measuring Isoaspartate in Human Serum Albumin. Molecules 26(21): 6709 https://doi.org/10.3390/molecules26216709
DeLuca et al. (2021). Generation and diversification of recombinant monoclonal antibodies for studying mitosis. eLife 10: e72093 https://doi.org/10.7554/eLife.72093
Kierkels et al. (2021). Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Mol Ther Methods & Clin Dev 22: 388-400 https://doi.org/10.1016/j.omtm.2021.06.011
Dang et al. (2021). Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nat Structural & Mol Bio 28: 426-434. https://doi.org/10.1038/s41594-021-00584-8
Dai et al. (2021). Polymeric assembly of endogenous Tuberous Sclerosis Protein Complex. Biochemistry 60(23):1808-1821 https://doi.org/10.1021/acs.biochem.1c00269
Radichev et al. (2020). Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor. Cellular Immunol 358: 104224. https://doi.org/10.1016/j.cellimm.2020.104224
Bratslavsky & Tsimafeyeu (2019). 499P – Identification of first-in-class, naturally occurring LAG3 checkpoint inhibitor. Annals of Oncology 30(5). https://www.sciencedirect.com/science/article/pii/S092375341958721X
Kierkels, G.J.J. (2019). TCR engineered T cell therapy from concepts to clinic. Utretch University Repository. https://dspace.library.uu.nl/handle/1874/379914
Arboleda-Velasquez et al. (2019). Resistance to autosomal dominant Alzheimer’s disease APOE3 Christchurch homozygote: a case report. Nat Med 25 1680-1683. https://doi.org/10.1038/s41591-019-0611-3
